W. R. Berkley
WRB
$73.84
+2.29%
W.R. Berkley Corporation is an insurance holding company that underwrites commercial casualty insurance through its subsidiaries, specializing in niche products such as excess and surplus lines, workers' compensation, and reinsurance. As a leading player in the property and casualty insurance industry, it distinguishes itself through a focus on specialized, non-standard risks and disciplined underwriting. The current investor narrative centers on the company's ability to sustain underwriting profitability and premium growth amid a competitive market, with recent attention on its consistent earnings performance and capital management strategies.…
WRB
W. R. Berkley
$73.84
Related headlines
Investment Opinion: Should I buy WRB Today?
Rating: Hold. WRB is a well-capitalized insurer with strong ROE and cash flow, but its decelerating growth and margin compression limit upside potential. The analyst consensus is neutral with only 3 analysts, and the average EPS estimate of $5.06 implies a forward P/E of 14.3x, close to the current 15.07x.
Supporting Evidence: WRB's trailing P/E of 15.65x is a 29% discount to the industry average of 22.0x, but its own historical median is 14.5x, suggesting fair value. Revenue growth of 1.4% YoY lags the industry average of 5-7%, while ROE of 18.3% exceeds the industry median of 12%. Free cash flow of $3.43 billion supports a 2.5% dividend yield. The stock's 1-year return of +4.4% underperforms the S&P 500's +20.6%, reflecting relative weakness.
Risks & Conditions: This Hold would upgrade to Buy if revenue growth accelerates above 5% or if the P/E compresses below 12x, offering a wider margin of safety. It would downgrade to Sell if net income continues to decline YoY or if operating margin falls below 14%. Overall, WRB appears fairly valued relative to its history and peers, given its growth trajectory and margin trends.
Sign up to view all
WRB 12-Month Price Forecast
WRB's outlook is balanced: its strong ROE and conservative balance sheet provide a floor, but top-line stagnation and margin erosion cap upside. The base case of range-bound trading (68-78) is most likely, with a 55% probability. A bull case requires a hard market catalyst, while a bear case could materialize if margins continue to deteriorate. The neutral stance reflects the lack of a clear catalyst to break the stock out of its current range. Upgrading to bullish would require evidence of margin stabilization or revenue acceleration; downgrading to bearish would follow a sustained decline in net income.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on W. R. Berkley's 12-month outlook, with a consensus price target around $95.99 and implied upside of +30.0% versus the current price.
Average Target
$95.99
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$59 - $96
Analyst target range
Insufficient analyst coverage available. Only 3 analysts provide estimates, with a consensus EPS estimate of $5.06 for the current fiscal year. The lack of a broader consensus and target price data limits the ability to assess market sentiment. Limited coverage typically indicates a mid-cap stock with moderate institutional interest, which can lead to higher volatility and less efficient price discovery. Investors should rely more on fundamental analysis and technical levels for decision-making.
Drowning in data?
Find the real signal!
Bulls vs Bears: WRB Investment Factors
WRB presents a mixed picture: strong capital efficiency (18.3% ROE) and a conservative balance sheet (0.29 D/E) are offset by decelerating revenue growth (1.4% YoY) and margin compression (operating margin down to 16.3%). The stock trades at a 29% discount to the industry P/E, but its own historical P/E range (7.85x-26.6x) suggests current levels are near the upper end. The bull case rests on valuation support and cash flow generation, while the bear case focuses on growth stagnation and margin erosion. The single most important tension is whether WRB can stabilize margins and reaccelerate growth; if margins continue to compress, the valuation discount may widen further.
Bullish
- Strong ROE Above Industry: WRB's return on equity (ROE) of 18.3% significantly exceeds the property & casualty insurance industry median of ~12%, demonstrating efficient capital utilization and superior profitability.
- Conservative Balance Sheet: With a debt-to-equity ratio of 0.29, well below the industry average of 0.5-0.7, WRB maintains conservative leverage, reducing financial risk and providing flexibility for dividends and buybacks.
- Robust Free Cash Flow: Trailing twelve-month free cash flow of $3.43 billion provides ample liquidity for shareholder returns and strategic investments, supporting the current dividend yield of 2.5%.
- Attractive Valuation vs Peers: WRB trades at a trailing P/E of 15.65x, a 29% discount to the industry average of 22.0x, offering a value entry point despite its superior ROE.
Bearish
- Decelerating Revenue Growth: Revenue growth slowed to 1.4% YoY in Q4 2025 from 4.2% in Q4 2024, indicating a mature market and limited top-line momentum, which may cap earnings expansion.
- Margin Compression Trends: Operating margin declined from 19.9% in Q4 2024 to 16.3% in Q4 2025, while net margin fell to 12.1% from 15.7%, reflecting rising expense ratios and competitive pressure.
- Net Income Decline: Net income dropped 22% YoY in Q4 2025 to $449.5 million from $576.1 million, signaling potential underwriting deterioration or investment losses.
- Limited Analyst Coverage: Only 3 analysts cover WRB, resulting in less efficient price discovery and higher uncertainty. The lack of a consensus target price makes valuation assessment less reliable.
WRB Technical Analysis
WRB is trading in a range-bound consolidation pattern, with a 1-year price change of +4.4% indicating minimal net movement. The current price of $72.19 sits at 79% of its 52-week range ($62.87–$78.96), suggesting the stock is closer to the high end but not overextended. This positioning implies moderate bullish sentiment, though the lack of a clear breakout above $78.96 or breakdown below $62.87 leaves the trend ambiguous. Over the past 3 months, the stock has gained 9.9%, while the 1-month return is +5.9%, indicating accelerating short-term momentum. However, the 1-year return of +4.4% lags the S&P 500's 20.6% gain, reflecting relative underperformance. The 1-month relative strength of +1.86 versus the S&P 500 suggests recent outperformance, but the 1-year relative strength of -16.23 highlights persistent weakness. The 52-week high of $78.96 acts as key resistance; a breakout above this level would signal a bullish reversal and potential for further upside. Support lies at the 52-week low of $62.87, and a breakdown below this could indicate a bearish trend continuation. With a beta of 0.29, WRB is significantly less volatile than the market, meaning it tends to move less than the S&P 500, which may appeal to risk-averse investors but also limits upside in strong market rallies.
Beta
0.29
0.29x market volatility
Max Drawdown
-19.0%
Largest decline past year
52-Week Range
$63-$79
Price range past year
Annual Return
+7.2%
Cumulative gain past year
| Period | WRB Return | S&P 500 |
|---|---|---|
| 1m | +8.2% | +1.0% |
| 3m | +11.9% | +7.9% |
| 6m | +6.7% | +8.5% |
| 1y | +7.2% | +20.1% |
| ytd | +6.5% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
WRB Fundamental Analysis
Revenue for the most recent quarter (Q4 2025) was $3.72 billion, representing a modest 1.4% year-over-year growth, decelerating from the 4.2% growth seen in Q4 2024. Over the trailing four quarters, revenue has grown from $3.67 billion (Q4 2024) to $3.72 billion, indicating a flattening trajectory. The Insurance-Domestic segment contributed $3.04 billion (82% of total), while Reinsurance-Global added $455 million (12%), showing the domestic business as the primary growth driver. The deceleration suggests a mature market environment, and the investment case hinges on margin stability rather than top-line acceleration. Net income for Q4 2025 was $449.5 million, down from $576.1 million in Q4 2024, reflecting a 22% decline. Gross margin improved to 20.6% from 25.2% a year ago, but operating margin compressed to 16.3% from 19.9%, indicating higher expense ratios. The net margin of 12.1% is below the industry average for P&C insurers (typically 15-20%), suggesting room for improvement. Despite the margin compression, the company remains profitable with a trailing twelve-month net income of $1.78 billion. The balance sheet is solid, with a debt-to-equity ratio of 0.29, well below the industry average of 0.5-0.7, indicating conservative leverage. Free cash flow for the trailing twelve months was $3.43 billion, providing ample liquidity for dividends and share buybacks. Return on equity (ROE) stands at 18.3%, above the industry median of ~12%, reflecting efficient capital utilization. The current ratio of 1.39 suggests adequate short-term liquidity, though insurance companies typically maintain higher ratios.
Quarterly Revenue
$3.7B
2025-12
Revenue YoY Growth
+1.4%
YoY Comparison
Gross Margin
20.6%
Latest Quarter
Free Cash Flow
$3.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is WRB Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 15.65x, while the forward P/E is 15.07x, implying a slight discount to expected earnings growth. The gap between trailing and forward P/E suggests the market anticipates modest earnings growth, consistent with the company's stable but decelerating revenue. Compared to the property & casualty insurance industry average P/E of 22.0x, WRB trades at a 29% discount (15.65x vs. 22.0x). This discount may be justified by its lower revenue growth (1.4% YoY) versus the industry average of 5-7%, but its superior ROE (18.3% vs. industry 12%) argues for a premium. The P/B ratio of 2.87x is above the industry average of 1.8x, reflecting the market's valuation of its book value. Historically, WRB's trailing P/E has ranged from 7.85x (Q1 2022) to 26.6x (Q2 2022), with a median of ~14.5x. The current 15.65x is near the upper end of this range, suggesting the stock is not cheap by its own history. This implies the market is pricing in optimistic expectations for underwriting profitability and investment income, leaving limited room for error.
PE
15.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 8x~27x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: WRB's net income declined 22% YoY in Q4 2025, and operating margin compressed from 19.9% to 16.3%, indicating rising expense ratios. The debt-to-equity ratio of 0.29 is low, but the current ratio of 1.39 is below the typical insurance industry benchmark of 1.5-2.0, suggesting potential liquidity strain. Revenue growth of just 1.4% YoY highlights a mature business with limited top-line catalysts, making earnings dependent on cost control and investment income.
Market & Competitive Risks: WRB's beta of 0.29 indicates low market correlation, but its 1-year relative strength of -16.23 versus the S&P 500 shows persistent underperformance. The stock trades near the upper end of its historical P/E range (15.65x vs median 14.5x), leaving limited room for multiple expansion. Competitive pressures in the property & casualty insurance market could further compress margins, especially if pricing softens. The lack of analyst coverage (only 3 analysts) increases information asymmetry and potential for sharp price moves on earnings surprises.
Worst-Case Scenario: A prolonged period of margin compression combined with a cyclical downturn in insurance pricing could drive net income lower, potentially triggering a re-rating to the lower end of the historical P/E range. If the P/E contracts to 10x (near the 7.85x low), the stock could fall to approximately $50.60 (based on forward EPS of $5.06), representing a 30% decline from the current price of $72.19. The 52-week low of $62.87 provides a nearer-term downside of 13%, but a severe scenario could see the stock test $50, a 31% loss.
FAQ
The key risks are: 1) Financial risk: net income declined 22% YoY in Q4 2025, and operating margin compressed from 19.9% to 16.3%, indicating potential underwriting deterioration. 2) Competitive risk: the property & casualty insurance market is highly competitive, and pricing pressure could further erode margins. 3) Macro risk: with a beta of 0.29, WRB is less correlated to the market, but rising interest rates could reduce the value of its investment portfolio. 4) Company-specific risk: limited analyst coverage (only 3 analysts) increases information asymmetry and potential for volatility on earnings surprises. The most severe risk is a prolonged soft market that drives net income down 15-20%, potentially pushing the stock to $55-60.
The 12-month outlook is balanced: the base case (55% probability) sees the stock trading in a range of $68-$78, with stable but low revenue growth and margins. The bull case (20% probability) targets $78-$85, driven by a hard insurance market and margin expansion. The bear case (25% probability) sees the stock falling to $55-$65 if margin compression continues. The most likely scenario is the base case, with the stock remaining near current levels. Key assumptions include revenue growth staying below 2% and operating margin holding around 16%. The AI assessment is neutral with medium confidence, reflecting the lack of a clear catalyst.
WRB's trailing P/E of 15.65x is a 29% discount to the property & casualty insurance industry average of 22.0x, suggesting undervaluation relative to peers. However, compared to its own historical P/E range of 7.85x to 26.6x (median ~14.5x), the current multiple is near the upper end, indicating it is not cheap by its own history. The P/B ratio of 2.87x is above the industry average of 1.8x, reflecting a premium on book value. The market appears to be pricing in expectations of stable profitability (18.3% ROE) but limited growth. Overall, WRB is fairly valued relative to its history and growth trajectory, with a slight discount to peers that may be justified by its lower revenue growth.
WRB offers a compelling risk/reward for value-oriented investors, with a trailing P/E of 15.65x (29% discount to the industry average of 22.0x) and a strong ROE of 18.3%. However, its decelerating revenue growth (1.4% YoY) and margin compression (operating margin down to 16.3%) limit upside potential. The stock is a good buy for those seeking a stable dividend yield (2.5%) and lower volatility (beta 0.29), but growth investors may find better opportunities elsewhere. The biggest downside risk is further margin erosion, which could push the stock toward the 52-week low of $62.87. Overall, WRB is a hold for existing shareholders and a cautious buy for new investors at current levels, provided they have a long-term horizon.
WRB is better suited for long-term investment due to its stable business model, strong ROE (18.3%), and consistent dividend yield (2.5%). Its low beta (0.29) and range-bound price action make it less attractive for short-term trading, as the stock lacks the volatility needed for meaningful short-term gains. The 1-year return of +4.4% underperforms the S&P 500, but the company's conservative balance sheet and free cash flow generation provide downside protection. A suggested minimum holding period is 3-5 years to allow for compounding of dividends and potential valuation re-rating. Short-term traders may find limited opportunities unless a breakout above $78.96 or breakdown below $62.87 occurs.
